48 results on '"Yu, Guang‐Tao"'
Search Results
2. Lymph node targeting strategy using a hydrogel sustained-release system to load effector memory T cells improves the anti-tumor efficacy of anti-PD-1
3. STAT3 promotes differentiation of monocytes to MDSCs via CD39/CD73-adenosine signal pathway in oral squamous cell carcinoma
4. Microwave-responsive gadolinium metal-organic frameworks nanosystem for MRI-guided cancer thermotherapy and synergistic immunotherapy
5. CN− and NH2− co-decorated graphdiynes: A theoretical investigation
6. Desiccation cracking behavior and its suppression methods in lateritic soil under drying and wetting cycles
7. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment.
8. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell.
9. LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma.
10. The role of oral microbiota in cancer
11. PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma
12. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment
13. Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
14. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
15. Advanced materials and technologies for oral diseases.
16. PFC@O2 Targets HIF-1α to Reverse the Immunosuppressive TME in OSCC
17. STAT3 promotes differentiation of monocytes to MDSCs via CD39/CD73-adenosine signal pathway in oral squamous cell carcinoma
18. Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma
19. TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma
20. B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma
21. Selective blockade of B7‐H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma
22. PFC@O 2 Targets HIF-1α to Reverse the Immunosuppressive TME in OSCC.
23. Genome-Wide Enhancer Analysis Reveals the Role of AP-1 Transcription Factor in Head and Neck Squamous Cell Carcinoma
24. AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma
25. Overexpression of p21-activated kinase 2 is correlated with high-grade oral squamous cell carcinomas
26. Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma
27. TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma
28. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma
29. The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis
30. Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model
31. Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
32. T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
33. LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma
34. Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma
35. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell
36. CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma
37. Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma
38. Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma
39. Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC
40. Epidermal Growth Factor Receptor Inhibition Reduces Angiogenesis via Hypoxia-Inducible Factor-1α and Notch1 in Head Neck Squamous Cell Carcinoma
41. Structures and Considerable Static First Hyperpolarizabilities: New Organic Alkalides (M+@n6adz)M‘- (M, M‘ = Li, Na, K; n = 2, 3) with Cation Inside and Anion Outside of the Cage Complexants
42. Theoretical Study on Stability and Properties of NC2O Isomers
43. Theoretical Study on Structures and Stability of C4P Isomers
44. Theoretical Study on Structures and Stability of NC3S Isomers
45. Microwave-responsive gadolinium metal-organic frameworks nanosystem for MRI-guided cancer thermotherapy and synergistic immunotherapy.
46. Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates.
47. Blockade of adenosine A2A receptor enhances CD8 + T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.
48. Structures and considerable static first hyperpolarizabilities: new organic alkalides (M+@n6adz)M'- (M, M'=Li, Na, K; n=2, 3) with cation inside and anion outside of the cage complexants.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.